Molecular Interactions of ASPP1 and ASPP2 with the P53 Protein Family and the Apoptotic Promoters PUMA and Bax

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2008 Aug 5

PMID 18676979

Citations 24

Authors

Seema Patel

Roger George

Flavia Autore

Franca Fraternali

John E Ladbury

Penka V Nikolova

Affiliations

Soon will be listed here.

Abstract

The apoptosis stimulating p53 proteins, ASPP1 and ASPP2, are the first two common activators of the p53 protein family that selectively enable the latter to regulate specific apoptotic target genes, which facilitates yes yet unknown mechanisms for discrimination between cell cycle arrest and apoptosis. To better understand the interplay between ASPP- and p53-family of proteins we investigated the molecular interactions between them using biochemical methods and structure-based homology modelling. The data demonstrate that: (i) the binding of ASPP1 and ASPP2 to p53, p63 and p73 is direct; (ii) the C-termini of ASPP1 and ASPP2 interact with the DNA-binding domains of p53 protein family with dissociation constants, K(d), in the lower micro-molar range; (iii) the stoichiometry of binding is 1:1; (iv) the DNA-binding domains of p53 family members are sufficient for these protein-protein interactions; (v) EMSA titrations revealed that while tri-complex formation between ASPPs, p53 family of proteins and PUMA/Bax is mutually exclusive, ASPP2 (but not ASPP1) formed a complex with PUMA (but not Bax) and displaced p53 and p73. The structure-based homology modelling revealed subtle differences between ASPP2 and ASPP1 and together with the experimental data provide novel mechanistic insights.

Citing Articles

Alternative splicing in the DBD linker region of p63 modulates binding to DNA and iASPP in vitro.

Lotz R, Osterburg C, Chaikuad A, Weber S, Akutsu M, Machel A Cell Death Dis. 2025; 16(1):4.

PMID: 39762243 PMC: 11704248. DOI: 10.1038/s41419-024-07320-2.

Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis by reducing p53 degradation.

Li S, Yang M, Zhao Y, Zhai Y, Sun C, Guo Y Nat Commun. 2024; 15(1):8425.

PMID: 39341821 PMC: 11439048. DOI: 10.1038/s41467-024-52739-y.

Reconciling ASPP-p53 binding mode discrepancies through an ensemble binding framework that bridges crystallography and NMR data.

Liu T, Huang S, Zhang Q, Xia Y, Zhang M, Sun B PLoS Comput Biol. 2024; 20(2):e1011519.

PMID: 38324587 PMC: 10878502. DOI: 10.1371/journal.pcbi.1011519.

ASPP2 binds to hepatitis C virus NS5A protein via an SH3 domain/PxxP motif-mediated interaction and potentiates infection.

Smirnov A, Magri A, Lotz R, Han X, Yin C, Harris M J Gen Virol. 2023; 104(9).

PMID: 37750869 PMC: 7615710. DOI: 10.1099/jgv.0.001895.

The Caenorhabditis elegans ASPP homolog APE-1 is a junctional protein phosphatase 1 modulator.

Beacham G, Wei D, Beyrent E, Zhang Y, Zheng J, Camacho M Genetics. 2022; 222(1).

PMID: 35792852 PMC: 9434228. DOI: 10.1093/genetics/iyac102.

References

Tidow H, Veprintsev D, Freund S, Fersht A . Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2). J Biol Chem. 2006; 281(43):32526-33. DOI: 10.1074/jbc.M604725200. View

Patel S, Bui T, Drake A, Fraternali F, Nikolova P . The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding. Biochemistry. 2008; 47(10):3235-44. DOI: 10.1021/bi7023207. View

Tidow H, Andreeva A, Rutherford T, Fersht A . Solution structure of ASPP2 N-terminal domain (N-ASPP2) reveals a ubiquitin-like fold. J Mol Biol. 2007; 371(4):948-58. DOI: 10.1016/j.jmb.2007.05.024. View

Benchimol S . p53--an examination of sibling support in apoptosis control. Cancer Cell. 2004; 6(1):3-4. DOI: 10.1016/j.ccr.2004.07.002. View

Kravchenko J, Ilyinskaya G, Komarov P, Agapova L, Kochetkov D, Strom E . Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci U S A. 2008; 105(17):6302-7. PMC: 2327210. DOI: 10.1073/pnas.0802091105. View

Cho Y, Gorina S, Jeffrey P, Pavletich N . Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994; 265(5170):346-55. DOI: 10.1126/science.8023157. View

Nikolova P, Wong K, DeDecker B, Henckel J, Fersht A . Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations. EMBO J. 2000; 19(3):370-8. PMC: 305574. DOI: 10.1093/emboj/19.3.370. View

Fraternali F, Cavallo L . Parameter optimized surfaces (POPS): analysis of key interactions and conformational changes in the ribosome. Nucleic Acids Res. 2002; 30(13):2950-60. PMC: 117037. DOI: 10.1093/nar/gkf373. View

Flores E, Tsai K, Crowley D, Sengupta S, Yang A, McKeon F . p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 2002; 416(6880):560-4. DOI: 10.1038/416560a. View

10.

Ko L, Prives C . p53: puzzle and paradigm. Genes Dev. 1996; 10(9):1054-72. DOI: 10.1101/gad.10.9.1054. View

11.

Bullock A, Henckel J, DeDecker B, Johnson C, Nikolova P, Proctor M . Thermodynamic stability of wild-type and mutant p53 core domain. Proc Natl Acad Sci U S A. 1998; 94(26):14338-42. PMC: 24967. DOI: 10.1073/pnas.94.26.14338. View

12.

Haupt Y, Rowan S, Shaulian E, Vousden K, Oren M . Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 1995; 9(17):2170-83. DOI: 10.1101/gad.9.17.2170. View

13.

Urist M, Prives C . p53 leans on its siblings. Cancer Cell. 2002; 1(4):311-3. DOI: 10.1016/s1535-6108(02)00064-8. View

14.

Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X . ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol. 2004; 24(3):1341-50. PMC: 321425. DOI: 10.1128/MCB.24.3.1341-1350.2004. View

15.

OConnor D, Bergamaschi D, Trigiante G, Hsieh J, Zhong S, Campargue I . ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 2001; 8(4):781-94. DOI: 10.1016/s1097-2765(01)00367-7. View

16.

Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

17.

Kleinjung J, Fraternali F . POPSCOMP: an automated interaction analysis of biomolecular complexes. Nucleic Acids Res. 2005; 33(Web Server issue):W342-6. PMC: 1160130. DOI: 10.1093/nar/gki369. View

18.

Stuart A, Fiser A, Sanchez R, Melo F, Sali A . Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 2000; 29:291-325. DOI: 10.1146/annurev.biophys.29.1.291. View

19.

Robinson R, Lu X, Jones E, Siebold C . Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73. Structure. 2008; 16(2):259-68. DOI: 10.1016/j.str.2007.11.012. View

20.

Bell H, Dufes C, OPrey J, Crighton D, Bergamaschi D, Lu X . A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo. J Clin Invest. 2007; 117(4):1008-18. PMC: 1810568. DOI: 10.1172/JCI28920. View